FLT3 and acute leukemia: FLT3-ITD patient samples and cell lines have increased expression of GLI2, and FLT3-ITD transgenic mice show rapid progression from myeloproliferation to acute leukemia when crossed with SmoM2 transgenic mice that have constitutive HH activation (89).